Visualitzant VHIO - Articles científics per títol
Ara mostrant els elements 99-118 d 846
-
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population
(Oxford University Press, 2019-05-01) -
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
(American Society of Clinical Oncology, 2023-10-20) -
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
(Nature Portfolio, 2023-03-13) -
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer
(American Association for Cancer Research, 2021-11-01) -
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
(MDPI, 2021-04-17) -
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
(American Association for Cancer Research, 2021-05-27) -
Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
(MDPI, 2020-04-04) -
BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy
(Nature Portfolio, 2022-11-19)